Press articles
|
Bayer/Algeta's prostate cancer drug alpharadin garners interest for use in earlier disease setting
Log In or register to access
| Oncology | Oncology | Stephanie Hawthorne | English | BioPharm Insight November 2011 | Nov 2011 |
|
Healthcare Companies Eye Move into Rural Segments in Asian Developing Markets
Log In or register to access
| All | Emerging Markets, All | Stephen Potts | English | BioPharm Insight April 2011 | April 2011 |
|
Medivation could attract Astellas bid if Dimebon program terminated, healthcare advisors suggest
Log In or register to access
| Oncology | Oncology, All | Gordon Gochenauer | English | BioPharm Insight May 2011 | May 2011 |
|
Endocyte's EC145: tough environment for conditional EU approval, yet companion diagnostic and unmet need may weigh in favour
Log In or register to access
| Oncology | Oncology, All | Jay Grisolano | English | BioPharm Insight May 2011 | May 2011 |
|
Nektar's NKTR-102 unlikely to secure accelerated approval in Ovarian Cancer
Log In or register to access
| Oncology | Oncology, All | Gordon Gochenauer | English | BioPharm Insight May 2011 | May 2011 |
|
Multinational pharma firms need to adapt fast to stay competitive in Asia-Pacific
Log In or register to access
| All | Emerging Markets, All | Mark Sales | English | Campaign Asia October 2010 | October 2010 |
|
The Challenges of Cancer Treatment in China
Log In or register to access
| Oncology | Emerging Markets, All | Ian Hicks; Lucy Liu; Linda Zhao (Draco Healthcare Consulting) | English | China Business Review January 2011 | January 2011 |
|
Developing Customer Trust in a Multi-Channel Environment.
Log In or register to access
| All | Stakeholder Effectiveness&Brand Marketing, All | Mark Sales | English | DTC Perspectives December 2010 | December 2010 |
|
Driving Traffic - DTC Online Marketing: The Online Content Strategy Imperative
Log In or register to access
| All | MROCs, social listening, All | Brian Mondry | English | DTC Perspectives Sept 2010 | Sept 2010 |
|
What’s the DTC Payoff? Trends in DTC Awareness and Action: Understanding the Impact of Investment Levels
Log In or register to access
| All | Health Economic &Patient Outcomes, Market Access, Pricing &Reimbursement , All | Kathy Annunziata | English | DTC Perspectives, June 2010 | June 2010 |
|
Public Policy Myths - Does DTC Drive Up the Costs of Consumer-Advertised Products?
Log In or register to access
| All | Stakeholder Effectiveness & Brand Marketing | Ken Sobel | English | DTC Perspectives, March 2010 | March 2010 |
|
Different Forecasting Methods in the US and Europe
Log In or register to access
| All | Forecasting & Epidemiology, Startegic Planning, Pipeline planning, Portfolio modeling | Kevin Norell | English | eyeforpharma April 2010 | April 2010 |
|
Biomarkers and Oncology Forecasting: How to Hit a Moving Target
Log In or register to access
| Oncology | Oncology, All | Dr. Robert Ramsey | English | eyeforpharma August 2010 | August 2010 |
|
Forecasting for 'Pharmerging' Markets
Log In or register to access
| All | Emerging Markets, Forecasting & Epidemiology, Pipeline planning, Portfolio planning, Strategic Planning | Kevin Norell | English | eyeforpharma July 2010 | July 2010 |
|
Forecasting for Complex Diseases
Log In or register to access
| All | Forecasting & Epidemiology, Disease Epidemiology, Pipeline planning, Portfolio Planning, Strategic Planning | David Robinson | English | eyeforpharma June 2010 | June 2010 |